Holen Sie sich die Stockscreener-App
1.28
5.88%
-0.08
Handel nachbörslich:
1.29
0.01
+0.78%
Schlusskurs vom Vortag:
$1.36
Offen:
$1.36
24-Stunden-Volumen:
1.60M
Relative Volume:
1.24
Marktkapitalisierung:
$488.95M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.3474
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
-4.48%
1M Leistung:
+0.00%
6M Leistung:
+16.36%
1J Leistung:
-27.68%
1-Tages-Spanne:
$1.28
$1.36
1-Wochen-Bereich:
$1.28
$1.37
52-Wochen-Spanne:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.28 | 519.51M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
What dividend safety rating applies to Standard BioTools Inc. (FLB) stockJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
How high can Standard BioTools Inc. stock goWeekly Investment Summary & AI Forecasted Entry and Exit Points - newser.com
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Can swing trading help recover from Standard BioTools Inc. lossesGold Moves & AI Forecast for Swing Trade Picks - newser.com
Standard BioTools’ (LAB) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
Can Standard BioTools Inc. hit a new high this monthPortfolio Return Summary & Expert Approved Trade Ideas - newser.com
What recovery options are there for Standard BioTools Inc.Take Profit & Verified Entry Point Signals - newser.com
How Standard BioTools Inc. stock compares to growth peersWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Will a bounce in Standard BioTools Inc. offer an exitInsider Buying & Accurate Entry/Exit Alerts - newser.com
Is Standard BioTools Inc a good long term investmentSwing Trading Watchlist & Invest Now – Opportunity Window Closing - earlytimes.in
Is Standard BioTools Inc FLB a good long term investmentEconomic Impact on Stocks & Access Our Free Weekly Investment Letter - earlytimes.in
Standard BioTools Inc Stock Analysis and ForecastStock Valuation Metrics & Free Unlock Exclusive Strategies - earlytimes.in
What drives Standard BioTools Inc stock priceSupport Level Holds & Low Cost Stock Picks - earlytimes.in
What analysts say about Standard BioTools Inc stockStock Buyback Announcements & Minimal Investment Profits - earlytimes.in
What analysts say about Standard BioTools Inc FLB stockBlue Chip Stock Analysis & Exceptional Profit Trading - earlytimes.in
Standard BioTools jumps on sale of SomaLogic to Illumina - MSN
Goldman Sachs Group Inc. Cuts Stock Position in Standard BioTools Inc. $LAB - MarketBeat
Portfolio Shifts: Will Standard BioTools Inc. face regulatory challengesVolume Spike & Fast Exit and Entry Strategy Plans - خودرو بانک
Earnings Miss: Can Standard BioTools Inc scale operations efficientlyJuly 2025 Closing Moves & Safe Entry Momentum Tips - خودرو بانک
Volatility Watch: Is RFPRFs ROIC above industry averageQuarterly Earnings Summary & Verified Short-Term Trading Plans - khodrobank.com
Pacific Capital Partners Ltd Sells 200,000 Shares of Standard BioTools Inc. $LAB - MarketBeat
Buyback Watch: How does Standard BioTools Inc correlate with NasdaqTrade Risk Assessment & Fast Entry Momentum Alerts - خودرو بانک
ETF Watch: Is Standard BioTools Inc impacted by rising ratesWeekly Trend Report & Weekly Stock Breakout Alerts - خودرو بانک
CEO Change: Is Standard BioTools Inc impacted by rising ratesStop Loss & Reliable Volume Spike Alerts - خودرو بانک
Breakout Watch: Is APPS a strong candidate for buy and holdM&A Rumor & High Accuracy Swing Entry Alerts - خودرو بانک
Standard BioTools announces workforce reduction and restructuring plan By Investing.com - Investing.com Canada
Standard BioTools announces workforce reduction and restructuring plan - Investing.com India
Standard BioTools to Cut 15% of Workforce Amid Restructuring - 富途牛牛
Standard BioTools Announces Workforce Reduction Plan - TipRanks
Volatility Watch: Is Standard BioTools Inc stock a smart retirement pick2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Bear Alert: Will Tradeweb Markets Inc. benefit from government policy2025 Fundamental Recap & Long-Term Investment Growth Plans - خودرو بانک
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Standard Biotools Inc-Aktie (LAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L | Director |
Sep 04 '25 |
Buy |
1.28 |
250,000 |
319,350 |
60,775,000 |
| Casdin Partners Master Fund, L | Director |
Sep 03 '25 |
Buy |
1.27 |
250,000 |
316,400 |
60,525,000 |
| Casdin Partners Master Fund, L | Director |
Aug 22 '25 |
Buy |
1.26 |
200,000 |
252,680 |
59,950,000 |
| Casdin Partners Master Fund, L | Director |
Aug 25 '25 |
Buy |
1.24 |
200,000 |
248,180 |
60,150,000 |
| Casdin Partners Master Fund, L | Director |
Aug 26 '25 |
Buy |
1.26 |
125,000 |
157,938 |
60,275,000 |
| Casdin Partners Master Fund, L | Director |
Aug 15 '25 |
Buy |
1.22 |
150,000 |
183,210 |
59,750,000 |
| Casdin Partners Master Fund, L | Director |
Aug 14 '25 |
Buy |
1.21 |
133,220 |
161,543 |
59,600,000 |
| Casdin Partners Master Fund, L | Director |
Aug 13 '25 |
Buy |
1.31 |
75,000 |
98,280 |
59,466,780 |
| Kim Hanjoon Alex | Chief Financial Officer |
May 23 '25 |
Sale |
0.94 |
1,428 |
1,344 |
930,286 |
| Mackay Sean | SVP & Chief Business Officer |
May 23 '25 |
Sale |
0.94 |
13,217 |
12,437 |
843,076 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):